The Background Many studies have highlighted a link between stress and multiple sclerosis (MS), including research that has shown that norepinephrine (a regulator of stress) is implicated in the mouse model...

A short video summarising the key findings of a recent paper, titled "Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple...

The U.S. Food and Drug Administration recently issued a safety communication on the use of gadolinium-based contrast agents for Magnetic Resonance Imaging (MRI).  As this has relevance for many people...

Our new video, "Reflections", features a selection of positive, personal insights from members of the multiple sclerosis (MS) community worldwide. The quotes used have been taken from online news articles,...

In 2013, the team from Overcoming Multiple Sclerosis (OMS) published a paper as part of the HOLISM research study in the International Journal of Neuroscience. This study showed that the consumption of...

A detailed look at the development of Innate Immunotherapeutics' potential Secondary Progressive MS treatment,...

The development of the International MS Genetics Consortium has led to the identification of more than 159 genetic variants that are associated with MS. However, we have to ask how important are these and are...

We recently conducted an interview with A/Prof An Goris (left) and Ph.D. student Kelly Hilven (right) from the Laboratory for Neuroimmunology at the University of Leuven in Belgium.  Earlier this year,...

A publication this week in BMJ Open has outlined a number of studies evaluating the use of stem cell therapy for people with progressive multiple sclerosis. These trials, being conducted by a team from...

The subject of progressive multifocal leukoencephalopathy (PML) has become very topical for people with multiple sclerosis, though it can still be quite confusing for many people. To help, we have prepared...